Amgen AMGN

NAS: AMGN | ISIN: US0311621009 7/01/2026

341,64 USD (+3,47%)

(+3,47%) 7/01/2026

Grafiek Amgen Inc

Grafiek Amgen Inc

1 dag1d 3,47%
1 week1w 4,27%
1 maand1m 6,35%
3 maanden3m 15,96%
6 maanden6m 15,03%
1 jaar1j 29,31%
5 jaar5j 43,25%

Amgen Inc in het nieuws

Toon enkel gratis nieuws

7 januari 2026 · Amgen To Present At The 44Th Annual J.p. Morgan Healthcare Conference · Persbericht

6 januari 2026 · Amgen Acquires Dark Blue Therapeutics, Bolstering Oncology Pipeline · Persbericht

19 december 2025 · Amgen Takes Action With The U.s. Government To Lower The Cost Of Medicines For American Patients · Persbericht

12 december 2025 · Fda Approves Uplizna® For Adults With Generalized Myasthenia Gravis · Persbericht

9 december 2025 · Amgen Announces 2026 First Quarter Dividend · Persbericht

24 november 2025 · Amgen To Present At Citi's 2025 Global Healthcare Conference · Persbericht

24 november 2025 · Amgen To Present At The 8Th Annual Evercore Isi Healthconx Conference · Persbericht

19 november 2025 · Fda Grants Full Approval To Amgen's Imdelltra® In Extensive Stage Small Cell Lung Cancer · Persbericht

8 november 2025 · Amgen's Repatha® Cuts Risk Of First Major Adverse Cardiovascular Events By 25% In Landmark Phase 3 Vesalius-Cv Trial · Persbericht

4 november 2025 · Amgen Reports Third Quarter 2025 Financial Results · Persbericht

Profiel Amgen Inc

Gezondheidstechnologie

Productie van biologische producten

Website: www.amgen.com

Hoofdzetel: Thousand Oaks, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe